BCG Vaccines Sales Market is expected to reach US$ 124.45 Mn. at a CAGR of 4.2% during the forecast period 2029. The rise in occurrence of tuberculosis across the globe and an increase in the number of drug-resistant tuberculosis cases are factors driving the growth of the global BCG vaccines sales market. Furthermore, the increase in initiatives by the United Nations (UN) to prevent tuberculosis would present profitable opportunities for emerging market players in the near future. Additionally, technological advancements aiding the development of BCG vaccine replacement hinder the market growth. Also, an increase in government initiatives and focus on vaccination programs globally boost market growth. At the same time, side-effects and a global shortage of BCG vaccine hamper the BCG vaccines sales market growth. Untapped market potential in developing regions is expected to provide worthwhile opportunities for BCG vaccines sales market size.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.To know about the Research Methodology :- Request Free Sample Report Bacillus Calmette–Guerin (BCG) vaccine is generally given to new born babies and up to six months old, but they can be vaccinated any time up to five years of age with a high incidence of TB. Tuberculosis is a severe infection, which damages the lungs and at times different parts of the body, for example, the joints, kidneys and bones. The BCG vaccine has existed for a long time and is a standout amongst the most broadly used of all conventional vaccines. The factors that drive the worldwide BCG vaccine market incorporate increment in the prevalence of tuberculosis, particularly in creating and undeveloped nations, and mechanical progression in the section of vaccine research. Nonetheless, symptoms of BCG vaccine and a worldwide lack of this vaccination hinder the development of the market. According to drug type, the immune BCG segment accounted for the highest share in 2022 and is also the fastest growing segment growing at a CAGR of 4.9% during the BCG vaccines sales market forecast period. The factors contributing toward the growth of this segment include the role of BCG in effectively helping TB prevention and as of now, there is no substitute vaccine for immune BCG. From a geographical point of view, Asia-Pacific is expected to occupy more than two-thirds of the overall market shares by 2029, due to increased demand in low-level income population, i.e. India, to prevent tuberculosis epidemic. For now, the region of Latin America, the Middle East, and Africa (LAMEA) is predicted to grow at the highest CAGR of 5.3% due to increased awareness and higher disposable income of consumers. The BCG Vaccines Sales Market Report contains in-depth analysis of major drivers, opportunities, challenges and their impact on the market. The BCG Vaccines Sales Market report also provides data about the government policies. Also provides detail information of BCG Vaccines. This research report also adds a snapshot of key competition, market trends during the forecast period, expected growth rates and the primary factors driving and impacting growth market data. This information will be beneficial or helpful to the decision makers. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding the Global BCG Vaccines Sales Market dynamics, structure by identifying and analysing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the Global BCG Vaccines Sales Market.
BCG Vaccines Sales Market Scope: Inquire before buying
Global BCG Vaccines Sales Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 93.30 Mn. Forecast Period 2023 to 2029 CAGR: 4.2% Market Size in 2029: US $ 124.45 Mn. Segments Covered: by Drug Type Immune BCG Therapy BCG by Usage Tuberculosis Bladder Cancer by End User Pediatrics Adults BCG Vaccines Sales Market, by Region:
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)BCG Vaccines Sales Market Key Players are:
1. AJ Vaccines 2. China National Pharmaceutical Group Corporation (Sinopharm) 3. Greensignal Bio Pharma Limited 4. Intervax Ltd 5. Japan BCG Laboratory 6. Merck & Company Inc 7. Sanofi S.A. 8. Serum Institute of India Pvt. Ltd. 9. Statens Serum Institute 10.Gsbpl C 11.Shanghai Institute of Biological Products 12.Japan BCG Laboratory Frequently Asked Questions: 1. Which region has the largest share in Global BCG Vaccines Sales Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global BCG Vaccines Sales Market? Ans: The Global Market is growing at a CAGR of 4.2% during forecasting period 2023-2029. 3. What is scope of the Global BCG Vaccines Sales market report? Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global BCG Vaccines Sales market? Ans: The important key players in the Global Market are – AJ Vaccines, China National Pharmaceutical Group Corporation (Sinopharm), Greensignal Bio Pharma Limited, Intervax Ltd, Japan BCG Laboratory, Merck & Company Inc, Sanofi S.A., Serum Institute of India Pvt. Ltd., Statens Serum Institute, Gsbpl C, Shanghai Institute of Biological Products, and Japan BCG Laboratory 5. What is the study period of this market? Ans: The Global BCG Vaccines Sales Market is studied from 2022 to 2029.
1. BCG Vaccines Sales Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. BCG Vaccines Sales Market: Dynamics 2.1. BCG Vaccines Sales Market Trends by Region 2.1.1. North America BCG Vaccines Sales Market Trends 2.1.2. Europe BCG Vaccines Sales Market Trends 2.1.3. Asia Pacific BCG Vaccines Sales Market Trends 2.1.4. Middle East and Africa BCG Vaccines Sales Market Trends 2.1.5. South America BCG Vaccines Sales Market Trends 2.2. BCG Vaccines Sales Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America BCG Vaccines Sales Market Drivers 2.2.1.2. North America BCG Vaccines Sales Market Restraints 2.2.1.3. North America BCG Vaccines Sales Market Opportunities 2.2.1.4. North America BCG Vaccines Sales Market Challenges 2.2.2. Europe 2.2.2.1. Europe BCG Vaccines Sales Market Drivers 2.2.2.2. Europe BCG Vaccines Sales Market Restraints 2.2.2.3. Europe BCG Vaccines Sales Market Opportunities 2.2.2.4. Europe BCG Vaccines Sales Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific BCG Vaccines Sales Market Drivers 2.2.3.2. Asia Pacific BCG Vaccines Sales Market Restraints 2.2.3.3. Asia Pacific BCG Vaccines Sales Market Opportunities 2.2.3.4. Asia Pacific BCG Vaccines Sales Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa BCG Vaccines Sales Market Drivers 2.2.4.2. Middle East and Africa BCG Vaccines Sales Market Restraints 2.2.4.3. Middle East and Africa BCG Vaccines Sales Market Opportunities 2.2.4.4. Middle East and Africa BCG Vaccines Sales Market Challenges 2.2.5. South America 2.2.5.1. South America BCG Vaccines Sales Market Drivers 2.2.5.2. South America BCG Vaccines Sales Market Restraints 2.2.5.3. South America BCG Vaccines Sales Market Opportunities 2.2.5.4. South America BCG Vaccines Sales Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For BCG Vaccines Sales Industry 2.8. Analysis of Government Schemes and Initiatives For BCG Vaccines Sales Industry 2.9. BCG Vaccines Sales Market Trade Analysis 2.10. The Global Pandemic Impact on BCG Vaccines Sales Market 3. BCG Vaccines Sales Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 3.1.1. Immune BCG 3.1.2. Therapy BCG 3.2. BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 3.2.1. Tuberculosis 3.2.2. Bladder Cancer 3.3. BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 3.3.1. Pediatrics 3.3.2. Adults 3.4. BCG Vaccines Sales Market Size and Forecast, by Region (2022-2029) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America BCG Vaccines Sales Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 4.1.1. Immune BCG 4.1.2. Therapy BCG 4.2. North America BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 4.2.1. Tuberculosis 4.2.2. Bladder Cancer 4.3. North America BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 4.3.1. Pediatrics 4.3.2. Adults 4.4. North America BCG Vaccines Sales Market Size and Forecast, by Country (2022-2029) 4.4.1. United States 4.4.1.1. United States BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 4.4.1.1.1. Immune BCG 4.4.1.1.2. Therapy BCG 4.4.1.2. United States BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 4.4.1.2.1. Tuberculosis 4.4.1.2.2. Bladder Cancer 4.4.1.3. United States BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 4.4.1.3.1. Pediatrics 4.4.1.3.2. Adults 4.4.2. Canada 4.4.2.1. Canada BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 4.4.2.1.1. Immune BCG 4.4.2.1.2. Therapy BCG 4.4.2.2. Canada BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 4.4.2.2.1. Tuberculosis 4.4.2.2.2. Bladder Cancer 4.4.2.3. Canada BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 4.4.2.3.1. Pediatrics 4.4.2.3.2. Adults 4.4.3. Mexico 4.4.3.1. Mexico BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 4.4.3.1.1. Immune BCG 4.4.3.1.2. Therapy BCG 4.4.3.2. Mexico BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 4.4.3.2.1. Tuberculosis 4.4.3.2.2. Bladder Cancer 4.4.3.3. Mexico BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 4.4.3.3.1. Pediatrics 4.4.3.3.2. Adults 5. Europe BCG Vaccines Sales Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 5.2. Europe BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 5.3. Europe BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 5.4. Europe BCG Vaccines Sales Market Size and Forecast, by Country (2022-2029) 5.4.1. United Kingdom 5.4.1.1. United Kingdom BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 5.4.1.2. United Kingdom BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 5.4.1.3. United Kingdom BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 5.4.2. France 5.4.2.1. France BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 5.4.2.2. France BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 5.4.2.3. France BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 5.4.3. Germany 5.4.3.1. Germany BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 5.4.3.2. Germany BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 5.4.3.3. Germany BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 5.4.4. Italy 5.4.4.1. Italy BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 5.4.4.2. Italy BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 5.4.4.3. Italy BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 5.4.5. Spain 5.4.5.1. Spain BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 5.4.5.2. Spain BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 5.4.5.3. Spain BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 5.4.6. Sweden 5.4.6.1. Sweden BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 5.4.6.2. Sweden BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 5.4.6.3. Sweden BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 5.4.7. Austria 5.4.7.1. Austria BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 5.4.7.2. Austria BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 5.4.7.3. Austria BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 5.4.8.2. Rest of Europe BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 5.4.8.3. Rest of Europe BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 6. Asia Pacific BCG Vaccines Sales Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 6.2. Asia Pacific BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 6.3. Asia Pacific BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 6.4. Asia Pacific BCG Vaccines Sales Market Size and Forecast, by Country (2022-2029) 6.4.1. China 6.4.1.1. China BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 6.4.1.2. China BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 6.4.1.3. China BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 6.4.2. S Korea 6.4.2.1. S Korea BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 6.4.2.2. S Korea BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 6.4.2.3. S Korea BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 6.4.3. Japan 6.4.3.1. Japan BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 6.4.3.2. Japan BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 6.4.3.3. Japan BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 6.4.4. India 6.4.4.1. India BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 6.4.4.2. India BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 6.4.4.3. India BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 6.4.5. Australia 6.4.5.1. Australia BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 6.4.5.2. Australia BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 6.4.5.3. Australia BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 6.4.6. Indonesia 6.4.6.1. Indonesia BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 6.4.6.2. Indonesia BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 6.4.6.3. Indonesia BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 6.4.7. Malaysia 6.4.7.1. Malaysia BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 6.4.7.2. Malaysia BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 6.4.7.3. Malaysia BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 6.4.8. Vietnam 6.4.8.1. Vietnam BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 6.4.8.2. Vietnam BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 6.4.8.3. Vietnam BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 6.4.9. Taiwan 6.4.9.1. Taiwan BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 6.4.9.2. Taiwan BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 6.4.9.3. Taiwan BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 6.4.10.2. Rest of Asia Pacific BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 6.4.10.3. Rest of Asia Pacific BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 7. Middle East and Africa BCG Vaccines Sales Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 7.2. Middle East and Africa BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 7.3. Middle East and Africa BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 7.4. Middle East and Africa BCG Vaccines Sales Market Size and Forecast, by Country (2022-2029) 7.4.1. South Africa 7.4.1.1. South Africa BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 7.4.1.2. South Africa BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 7.4.1.3. South Africa BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 7.4.2. GCC 7.4.2.1. GCC BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 7.4.2.2. GCC BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 7.4.2.3. GCC BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 7.4.3. Nigeria 7.4.3.1. Nigeria BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 7.4.3.2. Nigeria BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 7.4.3.3. Nigeria BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 7.4.4.2. Rest of ME&A BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 7.4.4.3. Rest of ME&A BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 8. South America BCG Vaccines Sales Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 8.2. South America BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 8.3. South America BCG Vaccines Sales Market Size and Forecast, by End User(2022-2029) 8.4. South America BCG Vaccines Sales Market Size and Forecast, by Country (2022-2029) 8.4.1. Brazil 8.4.1.1. Brazil BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 8.4.1.2. Brazil BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 8.4.1.3. Brazil BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 8.4.2. Argentina 8.4.2.1. Argentina BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 8.4.2.2. Argentina BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 8.4.2.3. Argentina BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America BCG Vaccines Sales Market Size and Forecast, by Drug Type (2022-2029) 8.4.3.2. Rest Of South America BCG Vaccines Sales Market Size and Forecast, by Usage (2022-2029) 8.4.3.3. Rest Of South America BCG Vaccines Sales Market Size and Forecast, by End User (2022-2029) 9. Global BCG Vaccines Sales Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading BCG Vaccines Sales Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. AJ Vaccines 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. China National Pharmaceutical Group Corporation (Sinopharm) 10.3. Greensignal Bio Pharma Limited 10.4. Intervax Ltd 10.5. Japan BCG Laboratory 10.6. Merck & Company Inc 10.7. Sanofi S.A. 10.8. Serum Institute of India Pvt. Ltd. 10.9. Statens Serum Institute 10.10. Gsbpl C 10.11. Shanghai Institute of Biological Products 10.12. Japan BCG Laboratory 11. Key Findings 12. Industry Recommendations 13. BCG Vaccines Sales Market: Research Methodology 14. Terms and Glossary